Navigation Links
Takeda Type 2 Diabetes Therapies, NESINA (alogliptin) and Fixed-Dose Combinations KAZANO (alogliptin and metformin HCl) and OSENI (alogliptin and pioglitazone), Are Now Available in Pharmacies in the United States
Date:6/17/2013

and OSENI

Acute pancreatitis: There have been postmarketing reports of acute pancreatitis. If pancreatitis is suspected, promptly discontinue NESINA, KAZANO, or OSENI.

Hypersensitivity: There have been postmarketing reports of serious hypersensitivity reactions in patients treated with alogliptin such as anaphylaxis, angioedema or severe cutaneous adverse reactions. In such cases, promptly discontinue NESINA, KAZANO, or OSENI, assess for other potential causes, institute appropriate monitoring and treatment, and initiate alternative treatment for diabetes. Use caution in a patient with a history of angioedema with another DPP-4i because it is unknown whether such patients will be predisposed to angioedema.

Hepatic effects: Postmarketing reports of hepatic failure, sometimes fatal. Causality cannot be excluded. Baseline liver test panel is recommended. If liver injury is detected, promptly interrupt NESINA, KAZANO, or OSENI and assess patient for probable cause, then treat cause if possible, to resolution or stabilization. Do not restart NESINA, KAZANO, or OSENI if liver injury is confirmed and no alternate etiology can be found. Use with caution in patients with hepatic impairment.

Hypoglycemia: Insulin and insulin secretagogues are known to cause hypoglycemia. A lower dose of the insulin or insulin secretagogue may be required to minimize the risk when used in combination with NESINA, KAZANO, or OSENI.

Macrovascular outcomes: There have been no clinical studies establishing conclusive evidence of macrovascular risk reduction with NESINA, KAZANO, OSENI, or any other anti-diabetic drug.

Adverse Reactions

Most common adverse reactions (>/=4% of patients treated with NESINA 25 mg and more frequently than in patients who received placebo) were nasopharyngitis (4.4%), headache (4.2%), and upper respiratory tract infection (4.2%).

Most common adverse reactions (>/=4% of patients treated with co-administration
'/>"/>

SOURCE Takeda Pharmaceutical Company Limited
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Takeda to Acquire Multilab, Enhancing its Business Infrastructure in Brazil
2. Zacks Bull and Bear of the Day Highlights: Discover Financial Services, POSCO, AstraZeneca, Bayer and Takeda Pharmaceutical
3. Takeda Resubmits New Drug Applications to the United States Food and Drug Administration for Alogliptin and the Fixed-Dose Combination Alogliptin and Pioglitazone
4. Takeda Completes its Russian Pharmaceutical Manufacturing Facility
5. Takedas Deerfield Campus Ranked Among Chicagos Top 100 Workplaces in 2012
6. FDA Accepts Takeda and Lundbecks Submission of the New Drug Application for Vortioxetine for the Treatment of Major Depressive Disorder
7. Takeda Receives FDA Approval for Three New Type 2 Diabetes Therapies, NESINA (alogliptin) and Fixed-Dose Combinations OSENI (alogliptin and pioglitazone) and KAZANO (alogliptin and metformin HCl)
8. Takeda and Resolve Therapeutics Enter Autoimmune Partnership
9. Takeda Submits Marketing Authorisation Application for Vedolizumab in Moderately to Severely Active Ulcerative Colitis and Crohns Disease in the European Union
10. Takeda presenta la richiesta di autorizzazione allimmissione in commercio nellUnione Europea per Vedolizumab nella colite ulcerosa moderata-grave e nella malattia di Crohn
11. Scripps Research Institute and Takeda Pharmaceuticals Announce Expanded Research Collaboration
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/1/2015)...   Millstone Medical Outsourcing announced today that the ... Olive Branch, MS. Now totaling over 270,000 ... has added the capacity required to meet the high demand ... gives us the opportunity to grow in parallel with our ... "Two and a half years ago we were operating only ...
(Date:9/1/2015)... Sept. 1, 2015   Ivenix Inc. , ... management system, closed on a $42M round of ... Ventures. Cardinal Partners, CICA, Inc., Easterly Capital, Fidelity ... the round. This financing will support the company,s ... Leerink Partners LLC acted as the exclusive placement ...
(Date:9/1/2015)... 1. September 2015 In nur zwei ... Mitarbeitern hat die SHL Group schnell weltweit 3.000 ... rapides Wachstum auf dem Markt der ... und das Management von SHL wieder. ... ist weltweit führend in Design und Herstellung automatischer ...
Breaking Medicine Technology:Millstone Medical Outsourcing Announces Olive Branch Expansion 2Ivenix Inc. Secures $42 Million in Funding 2Ivenix Inc. Secures $42 Million in Funding 3SHL Group erreicht wichtigen Markstein von 3.000 Mitarbeitern 2
... ROSWELL, Ga., Sept. 1, 2011 Kimberly-Clark Health ... a double-digit price increase on synthetic exam gloves ... of raw materials, particularly butadiene and acrylonitrile.   ... for these raw materials along with inflationary pressures ...
... month, Floridians are recognizing "Plasma Protein Therapies Month," by ... throughout the "Sunshine State" and for the rare, genetic ... through plasma donation. Plasma protein therapies, which ... biotechnology product), are used every day to treat people ...
Cached Medicine Technology:Floridians Recognized for Role in Helping Rare Disease Patients Who Need Lifesaving Therapies 2Floridians Recognized for Role in Helping Rare Disease Patients Who Need Lifesaving Therapies 3
(Date:9/1/2015)... Minnesota (PRWEB) , ... September 01, 2015 , ... ... health care delivery options, Blue Cross and Blue Shield of Minnesota (Blue Cross) ... in 2016. , Based in San Francisco, Doctor On Demand provides immediate ...
(Date:9/1/2015)... ... 01, 2015 , ... Virginia entrepreneur Marcella Ellis, CEO and ... her firm’s success in the hair care and distribution industry through her combination ... will be providing “Look and learn” live demonstrations, as well as promoting her ...
(Date:9/1/2015)... ... September 01, 2015 , ... ... announced that Edge Information Management has been granted continued accreditation based on ... (BSCC). , “Achieving and maintaining this accreditation takes the involvement and ...
(Date:9/1/2015)... ... September 01, 2015 , ... With former IBMers among its founding ... since its inception more than 35 years ago. A pilot program begun by the ... - and, not just those intent on pursuing careers in these fields. The program ...
(Date:9/1/2015)... ... , ... Royal River Natural Foods, a locally-owned independent natural health store in ... years and found that, among those who had a stroke, people who used multivitamins ... of the September 2015 issue of “Natural Insights for Well Being,” which Royal River ...
Breaking Medicine News(10 mins):Health News:Blue Cross and Blue Shield of Minnesota names Doctor On Demand as preferred telehealth destination 2Health News:Blue Cross and Blue Shield of Minnesota names Doctor On Demand as preferred telehealth destination 3Health News:Beauty Entrepreneur creates hair extension smart machine and mobile app inspired by UBER technology 2Health News:Edge Information Management Granted Continued NAPBS Accreditation 2Health News:Edge Information Management Granted Continued NAPBS Accreditation 3Health News:Inmar Announces Program to Fuel Student Passion for STEM – with an Unconventional Twist 2Health News:New Study Finds Multivitamins Extend Life After Stroke, Retailer Reports 2
... condoms for nearly 9 months will soon be provided with ... as a promotional offer. More than 9 millions free condoms ... ,The proposal was announced by the Health Department, New ... is expected that the offer would materialise in the next ...
... carried a paper that gives us a different depth ... they are in the female reproductive tract. //This paper ... successful fertilization. ,Previous theory contends that the ... Gur and Haim Breitbart of the Bar-Ilan University, have ...
... vaccine has now established that bird flu vaccine ordered by the ... as effective as it is claimed to be. // ... named as generic H5N1 and it plans to enter clinical trials ... of the year, and is marketing it to the British government, ...
... condoms in school through installation of condom vending machines ... in Australia.// ,Kate Reynolds, who represents ... issue was health, not morals. ,"The facts are ... said. , ,"They are not telling their parents, ...
... deficit hyperactivity disorder (ADHD) is characterized by failure to ... performance in school, conduct problems and drug abuse. // ... treat this disease. But drug experts say that these ... carry the most serious type of warning labels. ...
... to be spurred by the inability or failure to ‘Gasp’. ... ascertain the probable cause of SIDS. // ,University ... the brain, that are capable of producing nervous impulses ... are called ‘pacemakers.' ,The research team, led by Professor ...
Cached Medicine News:
...
No. 1. 30 mm conventional blades. Thin well-rounded tips....
Open blade speculum designed for both temporal and superior approach ocular surgery. Thumb screw adjusting mechanism. Manufactured in titanium....
Adjustable lid speculum angled 45 degrees with 17 mm curved solid blades and aspiration ports to remove excess fluid from around the eye during ocular procedures....
Medicine Products: